BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9173770)

  • 1. [Clinical experiences with Climen in peri- and postmenopausal women].
    Husmann F
    Zentralbl Gynakol; 1997; 119(3):123-7. PubMed ID: 9173770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Estradiol valerate/cyproterone acetate in the treatment of climacteric syndrome].
    Zivný J; Skrenková J
    Ceska Gynekol; 1996 Oct; 61(5):294-6. PubMed ID: 9004975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of antiandrogens in hormone replacement therapy.
    Schneider HP
    Climacteric; 2000 Dec; 3 Suppl 2():21-7. PubMed ID: 11379383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine effects in Asian postmenopausal women treated with SH D 461 M and Prempak-C.
    Goh HH; McCarthy TG; Dramusic V; Costales A; Junge W; Ratnam SS
    Maturitas; 1994 Dec; 20(2-3):165-73. PubMed ID: 7715469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of different hormone replacement therapy regimens on circadian blood pressure profile and active renin in postmenopausal women.
    Zacharieva S; Kirilov G; Kalinov K; Shigarminova R; Nachev E; Orbetzova M; Atanassova I
    Gynecol Endocrinol; 2002 Dec; 16(6):461-7. PubMed ID: 12626033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application and factor analysis of the menopause rating scale [MRS] in a post-marketing surveillance study of Climen.
    Schneider HP; Rosemeier HP; Schnitker J; Gerbsch S; Turck R
    Maturitas; 2000 Dec; 37(2):113-24. PubMed ID: 11137330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding.
    Marslew U; Overgaard K; Riis BJ; Christiansen C
    Obstet Gynecol; 1992 Feb; 79(2):202-10. PubMed ID: 1309944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
    Savoca S; D'Agosta S; Lombardo G
    Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine effects in Asian postmenopausal women, treated with SH D 461 M and Prempak-C.
    Goh HH; McCarthy TG; Dramusic V; Costales A; Junge W; Ratnam SS
    Maturitas; 1995 Jan; 21(1):17-25. PubMed ID: 7731378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alleviation of the climacteric symptoms with oral sequential hormone replacement therapy.
    Chittacharoen A; Domhardt R; Manonai J; Theppisai U; Golbs S
    J Med Assoc Thai; 2004 Jan; 87(1):1-7. PubMed ID: 14971528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Splenopeptides for climacteric complaints. Comparison of ovarian stimulation with transdermal estradiol substitution].
    Lauritzen C; Teucher T; Schmitz H
    Arzneimittelforschung; 1995 Mar; 45(3):315-22. PubMed ID: 7741793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does vitamin D3 have negative effects on serum levels of lipids? A follow-up study with a sequential combination of estradiol valerate and cyproterone acetate and/or vitamin D3.
    Tuppurainen M; Heikkinen AM; Penttilä I; Saarikoski S
    Maturitas; 1995 Jun; 22(1):55-61. PubMed ID: 7666817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hormonal therapy in perimenopause].
    Zaĭdieva IaZ
    Akush Ginekol (Mosk); 1995; (3):28-30. PubMed ID: 7653724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effects of 17 beta-estradiol and norethisterone acetate in postmenopausal Thai women.
    Limpaphayom KK; Bunyavejchevin S
    J Med Assoc Thai; 2000 Apr; 83(4):407-16. PubMed ID: 10808701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Replacement hormonal therapy: effects on ECG parameters in postmenopausal women].
    Zatikian EP; Smetnik VP; Klimenchenko NI
    Ter Arkh; 1998; 70(10):33-7. PubMed ID: 9864801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transdermal estradiol--the possibility for replacement therapy in the postmenopause].
    Rachev E
    Akush Ginekol (Sofiia); 1994; 33(3):45-7. PubMed ID: 7793531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acceptability of continuous combined versus cyclical HRT: a French multicentric randomized clinical study].
    Drapier-Faure E; Azoulay C; Abramovici Y
    Gynecol Obstet Fertil; 2005; 33(7-8):498-504. PubMed ID: 16005674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hormone replacement therapy with femoston on hemostasis in peri- and postmenopausal women.
    Repina MA; Korzo TM; Zinina TA
    Med Sci Monit; 2002 Sep; 8(9):PI78-84. PubMed ID: 12218956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
    Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
    Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The climacteric and its hormonal treatment].
    Gvorgiev DB
    Akush Ginekol (Sofiia); 1993; 32(1):36-40. PubMed ID: 8172347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.